Hologic's breast-biopsy device gets CE Mark approval

11/6/2008 | HealthImaging.com

Hologic has secured European CE Mark approval for its Celero vacuum-assisted core biopsy device. The product is designed to reach lesions in the axilla, as well as other parts of the breast, during ultrasound imaging. Hologic also obtained clearance in Europe for other products, including the CeleroMark and CeleroMark-2S biopsy site identifiers.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC